COGT - Citi starts Cogent Biosciences at buy cites GI tumor drug potential
2024-02-08 14:11:11 ET
More on Cogent Biosciences
- AIM stock dips amid mixed results for post-COVID fatigue therapy
- Cogent Biosciences issues study updates on bezuclastinib, CGT4859
- Seeking Alpha’s Quant Rating on Cogent Biosciences
- Historical earnings data for Cogent Biosciences
- Financial information for Cogent Biosciences